MedPath

Dehydration of Stenfilcon A Contact Lenses Versus Delefilcon A Contact Lenses

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: stenfilcon A
Device: delefilcon A
Registration Number
NCT02366923
Lead Sponsor
Coopervision, Inc.
Brief Summary

The study will explore in vivo lens dehydration rates across a 12hr wear period for the study lenses.

Detailed Description

The study will explore in vivo lens dehydration rates across a 12hr wear period for the study lenses. The primary outcome variable for this study is the loss in lens weight over the day, which will indicate the amount of dehydration that has occured.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria
  1. Is at least 17 years of age and has full legal capacity to volunteer;
  2. Has read and signed an information consent letter;
  3. Is willing and able to follow instructions and maintain the appointment schedule;
  4. Is a current wearer of soft contact lenses and has worn them (any brand) more than 3 months.
  5. Is able to wear lenses for at least 12 hours a day.
Exclusion Criteria
  1. Is participating in any concurrent clinical study;

  2. Has any known active* ocular disease and/or infection;

  3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;

  4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;

  5. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;

  6. Has undergone refractive error surgery;

    • *For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
delefilcon Adelefilcon AEach subject will be randomized to wear the test lens in one eye and control lens in the other eye (contra lateral design).
stenfilcon Adelefilcon AEach subject will be randomized to wear the test lens in one eye and control lens in the other eye (contra lateral design).
stenfilcon Astenfilcon AEach subject will be randomized to wear the test lens in one eye and control lens in the other eye (contra lateral design).
delefilcon Astenfilcon AEach subject will be randomized to wear the test lens in one eye and control lens in the other eye (contra lateral design).
Primary Outcome Measures
NameTimeMethod
Moisture Retention (Mean) of Stenfilcon A and Delefilcon A12 Hours of Wear

Comparison between lens types up to and at 12 hours of wear of moisture retention by measuring relative percentage dehydration (RPD).

Moisture Retention (Median) of Stenfilcon A and Delefilcon A12 Hours of Wear

Comparison between lens types up to and at 12 hours of wear of moisture retention by measuring relative percentage dehydration (RPD).

Absolute Change in Water Content (Mean) of Stenfilcon A and Delefilcon A12 Hours of Wear

Comparison between lens types up to and at 12 hours of wear for the absolute change in water content (WC).

Absolute Change in Water Content (Median) of Stenfilcon A and Delefilcon A12 Hours of Wear

Comparison between lens types up to and at 12 hours of wear for the absolute change in water content (WC).

Secondary Outcome Measures
NameTimeMethod
Subjective Comfort of Stenfilcon A and Delefilcon AUp to 12 Hours of Wear

Subjective ratings for stenfilcon A and delefilcon A assessed at every hour up to 12 hours. (Scale 0-100, 0=very poor 100=excellent)

Trial Locations

Locations (1)

University of Waterloo School of Optometry

🇨🇦

Waterloo, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath